US 11642331
Glucocorticoid receptor modulators to treat pancreatic cancer
granted A61KA61K31/03A61K31/18
Quick answer
US patent 11642331 (Glucocorticoid receptor modulators to treat pancreatic cancer) held by Corcept Therapeutics Incorporated expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corcept Therapeutics Incorporated
- Grant date
- Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/03, A61K31/18, A61K31/337, A61K31/416